Stifel Nicolaus restated their hold rating on shares of Quintiles Transitional Holdings Inc. (NYSE:Q) in a report published on Friday. They currently have a $92.00 target price on the medical research company’s stock.

Several other research firms have also recently issued reports on Q. Zacks Investment Research upgraded shares of Quintiles Transitional Holdings from a hold rating to a buy rating and set a $101.00 price objective for the company in a research report on Thursday, July 27th. William Blair upgraded shares of Quintiles Transitional Holdings from a market perform rating to an outperform rating and raised their price objective for the stock from $70.10 to $93.42 in a research report on Friday. Jefferies Group LLC restated a hold rating and set a $94.00 price objective on shares of Quintiles Transitional Holdings in a research report on Friday. Barclays PLC set a $100.00 price objective on shares of Quintiles Transitional Holdings and gave the stock a buy rating in a research report on Friday. Finally, Citigroup Inc. restated a neutral rating and set a $96.00 price objective (up from $87.00) on shares of Quintiles Transitional Holdings in a research report on Wednesday, June 28th. Eleven research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus target price of $89.94.

Quintiles Transitional Holdings (Q) opened at 91.19 on Friday. The company’s 50 day moving average is $89.50 and its 200-day moving average is $82.85. Quintiles Transitional Holdings has a 1-year low of $70.10 and a 1-year high of $92.54. The stock has a market capitalization of $20.07 billion, a PE ratio of 201.75 and a beta of 0.64.

Quintiles Transitional Holdings (NYSE:Q) last released its quarterly earnings data on Thursday, August 3rd. The medical research company reported $1.09 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.04. Quintiles Transitional Holdings had a net margin of 0.82% and a return on equity of 15.68%. The firm had revenue of $1.97 billion during the quarter, compared to analysts’ expectations of $1.96 billion. During the same period last year, the business earned $0.93 earnings per share. Quintiles Transitional Holdings’s revenue was up 68.7% compared to the same quarter last year. Analysts forecast that Quintiles Transitional Holdings will post $4.57 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Stifel Nicolaus Reiterates “Hold” Rating for Quintiles Transitional Holdings Inc. (NYSE:Q)” was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/08/stifel-nicolaus-reiterates-hold-rating-for-quintiles-transitional-holdings-inc-nyseq.html.

Quintiles Transitional Holdings declared that its board has approved a stock buyback plan on Wednesday, May 24th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the medical research company to buy up to 5.4% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its stock is undervalued.

In other news, Director Jack M. Greenberg sold 6,092 shares of the firm’s stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $82.50, for a total value of $502,590.00. Following the completion of the transaction, the director now owns 2,930 shares of the company’s stock, valued at $241,725. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, major shareholder Cpp Investment Board Private H sold 7,131,165 shares of the firm’s stock in a transaction that occurred on Wednesday, May 31st. The shares were sold at an average price of $84.01, for a total transaction of $599,089,171.65. The disclosure for this sale can be found here. In the last three months, insiders sold 8,850,560 shares of company stock valued at $744,110,641. Insiders own 6.40% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of Q. Great Lakes Advisors LLC increased its position in shares of Quintiles Transitional Holdings by 19.9% in the second quarter. Great Lakes Advisors LLC now owns 111,021 shares of the medical research company’s stock worth $9,936,000 after buying an additional 18,432 shares in the last quarter. Cutter & CO Brokerage Inc. increased its position in shares of Quintiles Transitional Holdings by 4.2% in the second quarter. Cutter & CO Brokerage Inc. now owns 3,805 shares of the medical research company’s stock worth $341,000 after buying an additional 152 shares in the last quarter. Essex Financial Services Inc. purchased a new position in shares of Quintiles Transitional Holdings during the second quarter worth about $240,000. Meiji Yasuda Asset Management Co Ltd. increased its position in shares of Quintiles Transitional Holdings by 72.7% in the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 6,948 shares of the medical research company’s stock worth $622,000 after buying an additional 2,925 shares in the last quarter. Finally, ProVise Management Group LLC increased its position in shares of Quintiles Transitional Holdings by 99.0% in the second quarter. ProVise Management Group LLC now owns 8,277 shares of the medical research company’s stock worth $741,000 after buying an additional 4,117 shares in the last quarter. 91.83% of the stock is owned by institutional investors and hedge funds.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Analyst Recommendations for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.